Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development
by Tsvetelina Velikova, Metodija Sekulovski and Monika Peshevska-Sekulovska
 
Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database
by Connor Frey and Mahyar Etminan
 
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
 
Recent Progress in Antibody Epitope Prediction
by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
 
Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
by Chi Hun Song, Minchan Jeong, Hyukmin In, Ji Hoe Kim, Chih-Wei Lin and Kyung Ho Han
 
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
 
Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease
by Weronika Grąźlewska and Lucyna Holec-Gąsior
 
A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy
by Angel Justiz-Vaillant, Bijay Raj Pandit, Chandrashekhar Unakal, Sehlule Vuma and Patrick Eberechi Akpaka
 
Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment
by Hyukmin In, Minkyoung Park, Hyeonsik Lee and Kyung Ho Han
 
Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?
by Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov and Guergana Petrova
Views Article
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules
by Francesco Ferrara, Chiara Verduci, Emanuela Laconi, Andrea Mangione, Chiara Dondi, Marta Del Vecchio, Veronica Carlevatti, Andrea Zovi, Maurizio Capuozzo and Roberto Langella
Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?
by Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov and Guergana Petrova
From Cereal Grains to Immunochemistry—What Role Have Antibodies Played in the History of the Home Pregnancy Test
by Kinga Lis
A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy
by Angel Justiz-Vaillant, Bijay Raj Pandit, Chandrashekhar Unakal, Sehlule Vuma and Patrick Eberechi Akpaka
When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
by Marino Paroli and Maria Isabella Sirinian
Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease
by Weronika Grąźlewska and Lucyna Holec-Gąsior
Recent Progress in Antibody Epitope Prediction
by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management
by Panagiotis Gklinos and Ruth Dobson
Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
by Robert Pejchal, Anthony B. Cooper, Michael E. Brown, Maximiliano Vásquez and Eric M. Krauland
Downloads Article
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
Recent Progress in Antibody Epitope Prediction
by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
by Chi Hun Song, Minchan Jeong, Hyukmin In, Ji Hoe Kim, Chih-Wei Lin and Kyung Ho Han
Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management
by Panagiotis Gklinos and Ruth Dobson
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
by Monica L. Fernández-Quintero, Nancy D. Pomarici, Anna-Lena M. Fischer, Valentin J. Hoerschinger, Katharina B. Kroell, Jakob R. Riccabona, Anna S. Kamenik, Johannes R. Loeffler, James A. Ferguson, Hailee R. Perrett, Klaus R. Liedl, Julianna Han and Andrew B. Ward
Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
by Robert Pejchal, Anthony B. Cooper, Michael E. Brown, Maximiliano Vásquez and Eric M. Krauland
Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database
by Connor Frey and Mahyar Etminan
Exploring Parametric and Mechanistic Differences between Expi293FTM and ExpiCHO-STM Cells for Transient Antibody Production Optimization
by Jing Zhou, Guoying Grace Yan, David Cluckey, Caryl Meade, Margaret Ruth, Rhady Sorm, Amy S. Tam, Sean Lim, Constantine Petridis, Laura Lin, Aaron M. D’Antona and Xiaotian Zhong
When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
by Marino Paroli and Maria Isabella Sirinian
Back to TopTop